| RS2085987831 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2085999500 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Retinal arterial tortuosity |
| RS2086001179 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2086003529 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086004268 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2086020099 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2086024759 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS2086051201 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2086051828 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2086074876 |
VPS26C
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2086110956 |
MBTPS1
|
Health Risk |
Likely pathogenic |
Spondyloepiphyseal dysplasia, kondo-fu type |
| RS2086116982 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Gastric cancer |
| RS2086117562 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086120321 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086122414 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086123262 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086125359 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2086137107 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086169784 |
HSPD1
|
Health Risk |
Likely pathogenic |
— |
| RS2086182638 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2086193164 |
FAM20A
|
Health Risk |
Pathogenic |
— |
| RS2086193735 |
HSPD1
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 4, Hypomyelinating leukodystrophy 4 |
| RS2086196870 |
MADD
|
Health Risk |
Pathogenic |
MADD-related disorder, MADD-related disorder |
| RS2086204386 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2086219990 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2086231222 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2086233936 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086242608 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2086249404 |
COL17A1
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2086254952 |
FAM20A
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS2086255627 |
PRMT7
|
Health Risk |
Pathogenic |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS2086256572 |
COL17A1
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, COL17A1-related disorder |
| RS2086265807 |
COL17A1
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2086266709 |
COL17A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2086270467 |
COL17A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS2086285148 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086289400 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086293039 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2086299809 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086303574 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2086303843 |
GNAS
|
Health Risk |
Likely pathogenic |
Intellectual disability, Pseudohypoparathyroidism |
| RS2086308364 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2086308918 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086314131 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2086331407 |
COL17A1
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS2086341997 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2086354048 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2086356460 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2086356894 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2086359795 |
COL17A1
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2086393945 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2086398901 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2086401437 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086401774 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086410142 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2086411154 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086422796 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2086432758 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086453392 |
COL17A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS2086458638 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2086461800 |
MTFMT
|
Health Risk |
Pathogenic |
— |
| RS2086462942 |
COL17A1
|
Health Risk |
Likely pathogenic |
— |
| RS2086478717 |
DONSON
|
Health Risk |
Pathogenic |
— |
| RS2086510950 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2086518173 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS2086519334 |
DONSON
|
Health Risk |
Likely pathogenic |
— |
| RS2086520075 |
COL17A1
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, Junctional epidermolysis bullosa |
| RS2086534839 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS2086534991 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2086551043 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086553104 |
DLG3
|
Health Risk |
Likely pathogenic |
— |
| RS2086557212 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2086573243 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2086575319 |
SLC6A9
|
Health Risk |
Pathogenic |
Atypical glycine encephalopathy, Atypical glycine encephalopathy |
| RS2086580997 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2086610889 |
SYNE1
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2086635662 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2086635842 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS2086662769 |
DLG3;DLG3-AS1
|
Health Risk |
Pathogenic |
— |
| RS2086666403 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2086671320 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086672570 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086674096 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2086675006 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2086676230 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Gastric cancer |
| RS2086678681 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086680808 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086682689 |
ATM
|
Health Risk |
Pathogenic |
Colorectal cancer, Hereditary cancer-predisposing syndrome |
| RS2086686955 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2086687086 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2086687425 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2086687862 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2086687936 |
NPC2
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2086688013 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2086688080 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2086688174 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS2086689358 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2086689501 |
NPC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C2 |
| RS2086690343 |
ATM;C11orf65
|
Health Risk |
Pathogenic |
— |
| RS2086697982 |
MYO18B
|
Health Risk |
Likely pathogenic |
MYO18B-related disorder, MYO18B-related disorder |